Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216764694> ?p ?o ?g. }
- W3216764694 abstract "Abstract Importance The long-term effects of COVID-19 on the incidence of vascular diseases are unclear. Objective To quantify the association between time since diagnosis of COVID-19 and vascular disease, overall and by age, sex, ethnicity, and pre-existing disease. Design Cohort study based on population-wide linked electronic health records, with follow up from January 1 st to December 7 th 2020. Setting and participants Adults registered with an NHS general practice in England or Wales and alive on January 1 st 2020. Exposures Time since diagnosis of COVID-19 (categorised as 0-6 days, 1-2 weeks, 3-4, 5-8, 9-12, 13-26 and 27-49 weeks since diagnosis), with and without hospitalisation within 28 days of diagnosis. Main outcomes and measures Primary outcomes were arterial thromboses (mainly acute myocardial infarction and ischaemic stroke) and venous thromboembolic events (VTE, mainly pulmonary embolism and lower limb deep vein thrombosis). We also studied other vascular events (transient ischaemic attack, haemorrhagic stroke, heart failure and angina). Hazard ratios were adjusted for demographic characteristics, previous disease diagnoses, comorbidities and medications. Results Among 48 million adults, 130,930 were and 1,315,471 were not hospitalised within 28 days of COVID-19. In England, there were 259,742 first arterial thromboses and 60,066 first VTE during 41.6 million person-years follow-up. Adjusted hazard ratios (aHRs) for first arterial thrombosis compared with no COVID-19 declined rapidly from 21.7 (95% CI 21.0-22.4) to 3.87 (3.58-4.19) in weeks 1 and 2 after COVID-19, 2.80 (2.61-3.01) during weeks 3-4 then to 1.34 (1.21-1.48) during weeks 27-49. aHRs for first VTE declined from 33.2 (31.3-35.2) and 8.52 (7.59-9.58) in weeks 1 and 2 to 7.95 (7.28-8.68) and 4.26 (3.86-4.69) during weeks 3-4 and 5-8, then 2.20 (1.99-2.44) and 1.80 (1.50-2.17) during weeks 13-26 and 27-49 respectively. aHRs were higher, for longer after diagnosis, after hospitalised than non-hospitalised COVID-19. aHRs were also higher among people of Black and Asian than White ethnicity and among people without than with a previous event. Across the whole population estimated increases in risk of arterial thromboses and VTEs were 2.5% and 0.6% respectively 49 weeks after COVID-19, corresponding to 7,197 and 3,517 additional events respectively after 1.4 million COVID-19 diagnoses. Conclusions and Relevance High rates of vascular disease early after COVID-19 diagnosis decline more rapidly for arterial thromboses than VTEs but rates remain elevated up to 49 weeks after COVID_19. These results support continued policies to avoid COVID-19 infection with effective COVID-19 vaccines and use of secondary preventive agents in high-risk patients. Key points Question Is COVID-19 associated with higher long-term incidence of vascular diseases? Findings In this cohort study of 48 million adults in England and Wales, COVID-19 was associated with higher incidence, that declined with time since diagnosis, of both arterial thromboses [week 1: adjusted HR [aHR] 21.7 (95% CI 21.0-22.4) weeks 27-49: aHR 1.34 (1.21-1.48)] and venous thromboembolism [week 1: aHR 33.2 (31.3-35.2), weeks 27–49 1.80 (1.50-2.17)]. aHRs were higher, for longer, after hospitalised than non-hospitalised COVID-19. The estimated excess number of arterial thromboses and venous thromboembolisms was 10,500. Meaning Avoidance of COVID-19 infection through vaccination, and use of secondary preventive agents after infection in high-risk patients, may reduce post-COVID-19 acute vascular diseases." @default.
- W3216764694 created "2021-12-06" @default.
- W3216764694 creator A5002654680 @default.
- W3216764694 creator A5005247953 @default.
- W3216764694 creator A5007197795 @default.
- W3216764694 creator A5012263812 @default.
- W3216764694 creator A5014499175 @default.
- W3216764694 creator A5015955757 @default.
- W3216764694 creator A5017327595 @default.
- W3216764694 creator A5017489363 @default.
- W3216764694 creator A5031075065 @default.
- W3216764694 creator A5031681187 @default.
- W3216764694 creator A5032944464 @default.
- W3216764694 creator A5033011934 @default.
- W3216764694 creator A5036062380 @default.
- W3216764694 creator A5037523041 @default.
- W3216764694 creator A5038167665 @default.
- W3216764694 creator A5043322495 @default.
- W3216764694 creator A5043555409 @default.
- W3216764694 creator A5049125458 @default.
- W3216764694 creator A5051111103 @default.
- W3216764694 creator A5058224218 @default.
- W3216764694 creator A5066907464 @default.
- W3216764694 creator A5070304160 @default.
- W3216764694 creator A5073010916 @default.
- W3216764694 creator A5076124471 @default.
- W3216764694 creator A5081850154 @default.
- W3216764694 creator A5081911168 @default.
- W3216764694 creator A5083544354 @default.
- W3216764694 creator A5087822966 @default.
- W3216764694 date "2021-11-24" @default.
- W3216764694 modified "2023-10-06" @default.
- W3216764694 title "Association of COVID-19 with arterial and venous vascular diseases: a population-wide cohort study of 48 million adults in England and Wales" @default.
- W3216764694 cites W2052960256 @default.
- W3216764694 cites W2096633399 @default.
- W3216764694 cites W2581706023 @default.
- W3216764694 cites W2785715721 @default.
- W3216764694 cites W2980735114 @default.
- W3216764694 cites W3016808868 @default.
- W3216764694 cites W3034872024 @default.
- W3216764694 cites W3042916948 @default.
- W3216764694 cites W3043015313 @default.
- W3216764694 cites W3093404624 @default.
- W3216764694 cites W3094056855 @default.
- W3216764694 cites W3120200144 @default.
- W3216764694 cites W3130691645 @default.
- W3216764694 cites W3144274120 @default.
- W3216764694 cites W3158988459 @default.
- W3216764694 cites W3176922870 @default.
- W3216764694 cites W3185635616 @default.
- W3216764694 cites W3193768668 @default.
- W3216764694 cites W3203404865 @default.
- W3216764694 doi "https://doi.org/10.1101/2021.11.22.21266512" @default.
- W3216764694 hasPublicationYear "2021" @default.
- W3216764694 type Work @default.
- W3216764694 sameAs 3216764694 @default.
- W3216764694 citedByCount "3" @default.
- W3216764694 countsByYear W32167646942022 @default.
- W3216764694 countsByYear W32167646942023 @default.
- W3216764694 crossrefType "posted-content" @default.
- W3216764694 hasAuthorship W3216764694A5002654680 @default.
- W3216764694 hasAuthorship W3216764694A5005247953 @default.
- W3216764694 hasAuthorship W3216764694A5007197795 @default.
- W3216764694 hasAuthorship W3216764694A5012263812 @default.
- W3216764694 hasAuthorship W3216764694A5014499175 @default.
- W3216764694 hasAuthorship W3216764694A5015955757 @default.
- W3216764694 hasAuthorship W3216764694A5017327595 @default.
- W3216764694 hasAuthorship W3216764694A5017489363 @default.
- W3216764694 hasAuthorship W3216764694A5031075065 @default.
- W3216764694 hasAuthorship W3216764694A5031681187 @default.
- W3216764694 hasAuthorship W3216764694A5032944464 @default.
- W3216764694 hasAuthorship W3216764694A5033011934 @default.
- W3216764694 hasAuthorship W3216764694A5036062380 @default.
- W3216764694 hasAuthorship W3216764694A5037523041 @default.
- W3216764694 hasAuthorship W3216764694A5038167665 @default.
- W3216764694 hasAuthorship W3216764694A5043322495 @default.
- W3216764694 hasAuthorship W3216764694A5043555409 @default.
- W3216764694 hasAuthorship W3216764694A5049125458 @default.
- W3216764694 hasAuthorship W3216764694A5051111103 @default.
- W3216764694 hasAuthorship W3216764694A5058224218 @default.
- W3216764694 hasAuthorship W3216764694A5066907464 @default.
- W3216764694 hasAuthorship W3216764694A5070304160 @default.
- W3216764694 hasAuthorship W3216764694A5073010916 @default.
- W3216764694 hasAuthorship W3216764694A5076124471 @default.
- W3216764694 hasAuthorship W3216764694A5081850154 @default.
- W3216764694 hasAuthorship W3216764694A5081911168 @default.
- W3216764694 hasAuthorship W3216764694A5083544354 @default.
- W3216764694 hasAuthorship W3216764694A5087822966 @default.
- W3216764694 hasBestOaLocation W32167646941 @default.
- W3216764694 hasConcept C126322002 @default.
- W3216764694 hasConcept C127413603 @default.
- W3216764694 hasConcept C164705383 @default.
- W3216764694 hasConcept C207103383 @default.
- W3216764694 hasConcept C2776265017 @default.
- W3216764694 hasConcept C2777785093 @default.
- W3216764694 hasConcept C2778959117 @default.
- W3216764694 hasConcept C2780645631 @default.
- W3216764694 hasConcept C2780868729 @default.
- W3216764694 hasConcept C2908647359 @default.
- W3216764694 hasConcept C44249647 @default.